Cynthia Louise Flowers

CIK 1741455 · last filed 2026-01-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$339.8K

Companies

4

Total Filings

24

Lifetime Open-Market Net

$126.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LSTA	Director	95,446	$3.56	$339.8K	$0	4	2026-01-13
G1 Therapeutics, Inc. (GTHX) Delisted	Director	15,889	$7.15	$113.6K	$26.2K	9	2024-09-18
LISATA THERAPEUTICS, INC. (CLBS) Delisted	Director	145,847	$6.40	$932.8K	$0	5	2022-01-12
Kadmon Holdings, Inc. (KDMN) Delisted	Director	0	$9.50	$0	$100.4K	6	2021-11-09

Recent Filings · Page 3 of 3

24 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-01-16	LISATA THERAPEUTICS, INC. (CLBS) Delisted	Grant (A)	+12,121	$60.0K	EDGAR
2018-12-27	G1 Therapeutics, Inc. (GTHX) Delisted	Buy (P)	+1,420	$26.2K	EDGAR
2018-11-08	LISATA THERAPEUTICS, INC. (CLBS) Delisted	Grant (A)	—	$0	EDGAR
2018-06-11	G1 Therapeutics, Inc. (GTHX) Delisted	Grant (A)	—	$0	EDGAR

Showing 21–24 of 24

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.